Belatacept Injection
Last Updated: June 6, 2017
Status: Current
Belatacept Injection
Products Affected - Description
-
Nulojix lyophilized powder for solution for injection, Bristol-Myers Squibb
250 mg, vial, 1 count (NDC 00003-0371-13)
Reason for the Shortage
-
Bristol-Myers Squibb has Nulojix in short supply due to manufacturing delays.
Available Products
-
There is insufficient supply for usual ordering
Estimated Resupply Dates
-
Bristol-Myers Squibb has limited the distribution of Nulojix. They have product only for existing patients available through the US Nulojix Distribution Program. They have no estimated recovery date, but do not expect full recovery before the end of 2017. Nulojix is distributed by McKesson Plasma Biologics.
Related Shortages
| Azathioprine Tablets | Resolved |
| Cyclosporine (Modified) Oral Presentations | Resolved |
| Mycophenolate Sodium Tablets | Resolved |
| Tacrolimus Capsules | Resolved |
Updated
June 6, March 7, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
